Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Syncytial Virus Respiratory Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03332459
What this trial is testing

A Long-term Follow-up Study to Evaluate the Impact of Lumicitabine on the Incidence of Asthma and/or Wheezing in Infants and Children With a History of Respiratory Syncytial Virus Infection

Who this might be right for
Respiratory Syncytial Virus Infections
Janssen Research & Development, LLC 7
Large-scale testing (Phase 3)Looking for participantsNCT07232706
What this trial is testing

Prevention of RSV Infection in Infants by Administering Nirsevimab to Infants, With or Without Maternal RSV Vaccination

Who this might be right for
RSV Immunization
Centre Hospitalier Annecy Genevois 1,000
Testing effectiveness (Phase 2)Study completedNCT02254408
What this trial is testing

Presatovir in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus Infection of the Upper Respiratory Tract

Who this might be right for
Respiratory Syncytial Virus
Gilead Sciences 189
Testing effectiveness (Phase 2)Study completedNCT03303625
What this trial is testing

Evaluate the Safety, Tolerability and Immunogenicity of an Investigational RSV Vaccine Candidate (Ad26.RSV.preF) in Adults 18 to 50 Years of Age, and RSV-seropositive Toddlers 12 to 24 Months of Age

Who this might be right for
Respiratory Syncytial VirusesRespiratory Tract Infections
Janssen Vaccines & Prevention B.V. 48
Testing effectiveness (Phase 2)Study completedNCT04071158
What this trial is testing

A RSV VACCINE WHEN GIVEN TOGETHER WITH TDAP IN HEALTHY NONPREGNANT WOMEN AGED BETWEEN 18 TO 49 YEARS

Who this might be right for
Respiratory Tract Infection
Pfizer 713
Testing effectiveness (Phase 2)Study completedNCT05921903
What this trial is testing

A Study on the Immune Response and Safety of an RSV Vaccine When Given to Adults 18 Years of Age and Above Who Received Lung or Kidney Transplant and Are at an Increased Risk of Respiratory Syncytial Virus Lower Respiratory Tract Disease and Compared to Healthy Adults 50 Years of Age and Above

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 386
Large-scale testing (Phase 3)Study completedNCT05559476
What this trial is testing

A Study on the Immune Response and Safety Elicited by a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a Vaccine Against Influenza in Adults Aged 65 Years and Above

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 1,029
Early research (Phase 1)Study completedNCT02201303
What this trial is testing

Evaluation of Danirixin (GSK1325756) Inhibition of CD11b Cell Surface Expression

Who this might be right for
Infections, Respiratory Syncytial Virus
GlaxoSmithKline 40
Very early researchStudy completedNCT05148780
What this trial is testing

Acute Respiratory Infections in Global Outpatient Setting

Who this might be right for
Acute Respiratory Infection
Janssen Research & Development, LLC 245
Early research (Phase 1)Study completedNCT06917508
What this trial is testing

Evaluate the Drug-Drug Interaction of EDP-323 With Midazolam, Caffeine, and Rosuvastatin in Healthy Participants

Who this might be right for
RSV InfectionDrug Drug Interaction
Enanta Pharmaceuticals, Inc 24
Not applicableStudy completedNCT02602678
What this trial is testing

Prone Position Effects on Work of Breathing and Intrinsic PEEP in Children With Severe Acute Viral Bronchiolitis

Who this might be right for
Severe Bronchiolitis
Hospices Civils de Lyon 16
Large-scale testing (Phase 3)Ended earlyNCT04583280
What this trial is testing

Rilematovir in Infants and Children and Subsequently in Neonates Hospitalized With Acute Respiratory Tract Infection Due to Respiratory Syncytial Virus (RSV)

Who this might be right for
Respiratory Tract Infections
Janssen Research & Development, LLC 28
Large-scale testing (Phase 3)Study completedNCT02442427
What this trial is testing

"Palivizumab Therapy for RSV-bronchiolitis"

Who this might be right for
Respiratory Syncytial Virus-bronchiolitis
Hamad Medical Corporation 420
Testing effectiveness (Phase 2)Active Not RecruitingNCT06686654
What this trial is testing

Study of a Human Metapneumovirus/Respiratory Syncytial Virus mRNA Vaccine Candidate Encapsulated in a Lipid Nanoparticle-based Formulation in Adults Aged 60 Years and Older

Who this might be right for
Human Metapneumovirus ImmunizationRespiratory Syncytial Virus Immunization
Sanofi Pasteur, a Sanofi Company 1,530
Testing effectiveness (Phase 2)Looking for participantsNCT06684379
What this trial is testing

Study on Safety and Efficacy of Two Doses of PRS CK STORM in the Modulation of the Cytokine Storm in Patients With Acute Respiratory Infection Caused by SARS-Cov-2, Influenza A, Influenza B and Respiratory Syncytial Virus (RSV)

Who this might be right for
SARS-CoV-2Influenza, HumanRespiratory Syncytial Virus Infections+2 more
PEACHES BIOTECH 50
Not applicableStudy completedNCT01090557
What this trial is testing

Exhaled Nitric Oxide in Respiratory Syncytial Virus (RSV) Bronchiolitis: a Pilot Study

Who this might be right for
RSV InfectionBronchiolitis
Winthrop University Hospital 60
Early research (Phase 1)Study completedNCT06601192
What this trial is testing

Investigate the Effects of Zelicapavir (EDP-938) on QTc Interval in Healthy Adults

Who this might be right for
RSV InfectionQTc Interval
Enanta Pharmaceuticals, Inc 72
Testing effectiveness (Phase 2)Study completedNCT06097299
What this trial is testing

MRNA-1345, an mRNA Vaccine Targeting Respiratory Syncytial Virus, in Children 2 to <18 Years of Age at High Risk of Respiratory Syncytial Virus

Who this might be right for
Respiratory Syncytial Virus
ModernaTX, Inc. 349
Not applicableStudy completedNCT02853838
What this trial is testing

Chest Physiotherapy in Infants Between 0 and 12 Months Old With Acute Bronchiolitis SRV(+)

Who this might be right for
Bronchiolitis, Viral
Universidad del Desarrollo 204
Early research (Phase 1)WithdrawnNCT02864628
What this trial is testing

RSV-MVA-BN Vaccine Phase I Trial, Intranasal Application in Adults.

Who this might be right for
Respiratory Syncytial Virus Infections
Bavarian Nordic
Next Page